Resources
Transforming WHO Recommendations into Practice
This technical brief discusses how the West African countries within the Act | West portfolio have transformed WHO guidelines and recommendations into practical approaches to achieve interruption of onchocerciasis transmission.
Partnering with Countries to Achieve Lymphatic Filariasis Elimination
This technical brief discusses WHO's Global Programme to Eliminate Lymphatic Filariasis (GPELF) and Act | West's approach that is used to support countries to achieve LF elimination.
Severe Adverse Event Webinar
Adverse events (AEs) particularly severe adverse events (SAEs) during and following mass drug administration have a serious effect not only on the people who are affected directly, but also on the viability of the MOH’s national NTD control program.
Trachoma Surveys: Practical Approaches to Implementing WHO Guidance for Neglected Tropical Disease (NTD) Programs in the Context of COVID-19
Trachoma baseline surveys, trachoma impact surveys, trachoma surveillance surveys, and trichiasis-only surveys are key disease-specific assessments of trachoma elimination programs, used to start mass drug administration (MDA), monitor progress, decide when to stop MDA, and inform attainment of elimination of trachoma as a public health problem.
Practical Approaches to Implementing WHO Guidance for Neglected Tropical Disease (NTD) Programs in the Context of COVID-19: Lymphatic Filariasis (LF) Surveys
This resource document complements the World Health Organization’s (WHO’s) guidance for NTD programs released on July 27, 2020.
Considerations for developing and deploying cost and economic impact models in the elimination/control of 5 PCT NTDs
The economic impact model and supporting disease-specific tools estimate the direct and indirect economic impact, efficiencies, and societal benefits of investing in NTD programs and interventions. The workshop will explain how NTD programs can use the supporting tools to develop investment cases to advocate for domestic resources and prioritize NTD investments in a multi-disease environment. It will also describe how, with support from HKI and Deloitte, Sierra Leone’s NTD program will pilot these tools and serve as the advisor on country needs, program and financial data, user testing of the tools, and utilization of the outputs for advocacy. After incorporating the feedback from the pilot in Sierra Leone, the Act | West team will make the tools available to all supported countries to create investment cases that enhance advocacy efforts for domestic resource mobilization for NTD programming.
Lymphatic Filariasis Operational Research Updates from NTDSC
Updates on operational research for lymphatic filariasis were shared from the Neglected Tropical Diseases Support Center on January 16, 2020.
Improving Mass Drug Administration Tools
The Carter Center's Emily Griswold presents on improving mass drug administration tools on January 16, 2020.
High Quality Disease-Specific Assessment Implementation and Electronic Data Collection
RTI's Clara Burgert and Diana Lu talk about how to ensure high-quality standardized surveys on January 16, 2020.
Investigating and Responding to LF Survey Failures
RTI's Clara Burgert leads a panel discussion on how to investigate and respond to LF survey failures on January 15, 2020.